RSS   Newsletter   Contact   Advertise with us
Post Online Media

Eagle Pharmaceuticals names David Pernock chief commercial officer

Eagle PharmaceuticalsEagle Pharmaceuticals, a specialty pharmaceutical company, announced that David Pernock will join Eagle as president and chief commercial officer from January 2017.
Article continues below

READ MORE Fibrocell Science names David Pernock chief executive officer

Mr. Pernock is a pharmaceutical and biotechnology industry expert. He has served as a member of Eagle’s Board of Directors since April 2015.

Mr. Pernock served as Chairman of the Board of Directors and Chief Executive Officer (2010-2017) of Fibrocell, an autologous cell and gene therapy company.

Previously, Mr. Pernock held various positions at GlaxoSmithKline plc (GSK), most notably serving as Senior Vice President of Pharmaceuticals, Vaccines (Biologics), Oncology, Acute Care, and HIV Divisions.

Mr. Pernock served as President of Reliant Pharmaceuticals when Reliant was acquired by GSK.

He was President of SmithKline Beecham-Puerto Rico prior to the GSK merger. Furthermore, he served as a director of Martek Biosciences Corporation.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy